Law firms are investigating whether HCA Healthcare or senior management may have violated federal securities laws after the hospital operator cited a $400 million quarterly hit from an unfavorable payer mix.
Multiple law firms are investigating HCA Healthcare, Inc. over possible federal securities law violations or other unlawful business practices following the company’s July 14, 2026 preliminary second-quarter results. HCA sharply reduced its full-year 2026 profit outlook after reporting an unfavorable payer mix, a measure of the balance between privately insured, government-insured and uninsured patients, as uninsured volume rose mainly from patients who lost health insurance exchange coverage. The company said that shift reduced quarterly revenue by about $400 million. HCA cut its 2026 earnings forecast to $28.70 to $30.50 per share, set its revenue target at $77 billion to $79.5 billion from a prior $76.5 billion to $80 billion range, and projected adjusted EBITDA of $15.4 billion to $16.1 billion versus an earlier $15.55 billion to $16.45 billion. HCA shares fell $27.14, or 6.95%, to close at $363.60 on July 14, 2026. No lawsuit has been filed, and the investigations remain ongoing.